
Thomas J. Visone
Examiner (ID: 553, Phone: (571)270-7144 , Office: P/1651 )
| Most Active Art Unit | 1651 |
| Art Unit(s) | 1699, 4112, 1672, 1651, 1671 |
| Total Applications | 523 |
| Issued Applications | 262 |
| Pending Applications | 31 |
| Abandoned Applications | 239 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19120026
[patent_doc_number] => 11963987
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-23
[patent_title] => Hepatoprotection food composition and pharmaceutical composition with strains of lactic acid bacteria
[patent_app_type] => utility
[patent_app_number] => 17/320820
[patent_app_country] => US
[patent_app_date] => 2021-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 5418
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17320820
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/320820 | Hepatoprotection food composition and pharmaceutical composition with strains of lactic acid bacteria | May 13, 2021 | Issued |
Array
(
[id] => 19134539
[patent_doc_number] => 11969448
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-30
[patent_title] => Method for improving an effect of chemotherapeutic drug of gemcitabine on inhibiting pancreatic cancer and improving side effect of chemotherapeutic drug of Gemcitabine
[patent_app_type] => utility
[patent_app_number] => 17/317928
[patent_app_country] => US
[patent_app_date] => 2021-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6662
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17317928
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/317928 | Method for improving an effect of chemotherapeutic drug of gemcitabine on inhibiting pancreatic cancer and improving side effect of chemotherapeutic drug of Gemcitabine | May 11, 2021 | Issued |
Array
(
[id] => 17020783
[patent_doc_number] => 20210244654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => TOPICAL SKIN FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/301863
[patent_app_country] => US
[patent_app_date] => 2021-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18343
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17301863
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/301863 | TOPICAL SKIN FORMULATIONS | Apr 15, 2021 | Abandoned |
Array
(
[id] => 17383920
[patent_doc_number] => 20220031772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => COMPOSITIONS COMPRISING BACTERIAL STRAINS
[patent_app_type] => utility
[patent_app_number] => 17/231247
[patent_app_country] => US
[patent_app_date] => 2021-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21065
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231247
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/231247 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | Apr 14, 2021 | Abandoned |
Array
(
[id] => 16992242
[patent_doc_number] => 20210230662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => Methods for the Treatment of Solid Tumor Cancers Using Illudins and Biomarkers
[patent_app_type] => utility
[patent_app_number] => 17/230821
[patent_app_country] => US
[patent_app_date] => 2021-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4453
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17230821
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/230821 | Methods for the Treatment of Solid Tumor Cancers Using Illudins and Biomarkers | Apr 13, 2021 | Pending |
Array
(
[id] => 17154200
[patent_doc_number] => 20210315251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => FOOD ADDITIVE AND METHOD FOR MODULATING GUT MICROBIOTA PROFILE
[patent_app_type] => utility
[patent_app_number] => 17/301648
[patent_app_country] => US
[patent_app_date] => 2021-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12068
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17301648
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/301648 | FOOD ADDITIVE AND METHOD FOR MODULATING GUT MICROBIOTA PROFILE | Apr 8, 2021 | Abandoned |
Array
(
[id] => 19622890
[patent_doc_number] => 12161682
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-10
[patent_title] => Topical composition and method of improving skin diseases and dermatitis using the same
[patent_app_type] => utility
[patent_app_number] => 17/205127
[patent_app_country] => US
[patent_app_date] => 2021-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 14
[patent_no_of_words] => 7460
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17205127
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/205127 | Topical composition and method of improving skin diseases and dermatitis using the same | Mar 17, 2021 | Issued |
Array
(
[id] => 17198652
[patent_doc_number] => 20210338746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => COMPOSITIONS COMPRISING BACTERIAL STRAINS
[patent_app_type] => utility
[patent_app_number] => 17/204996
[patent_app_country] => US
[patent_app_date] => 2021-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19392
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17204996
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/204996 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | Mar 17, 2021 | Abandoned |
Array
(
[id] => 17080606
[patent_doc_number] => 20210275612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => METHOD FOR ALLEVIATING INFLAMMATION-RELATED DISORDER
[patent_app_type] => utility
[patent_app_number] => 17/191766
[patent_app_country] => US
[patent_app_date] => 2021-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3887
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17191766
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/191766 | METHOD FOR ALLEVIATING INFLAMMATION-RELATED DISORDER | Mar 3, 2021 | Abandoned |
Array
(
[id] => 19884153
[patent_doc_number] => 12269846
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-08
[patent_title] => CoV-2 (CoV-n) antibody neutralizing and CTL vaccines using protein scaffolds and molecular evolution
[patent_app_type] => utility
[patent_app_number] => 17/191519
[patent_app_country] => US
[patent_app_date] => 2021-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 21252
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17191519
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/191519 | CoV-2 (CoV-n) antibody neutralizing and CTL vaccines using protein scaffolds and molecular evolution | Mar 2, 2021 | Issued |
Array
(
[id] => 18036185
[patent_doc_number] => 20220380400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => IMPROVED METHOD FOR MANUFACTURING ALLULOSE
[patent_app_type] => utility
[patent_app_number] => 17/772651
[patent_app_country] => US
[patent_app_date] => 2020-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13970
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17772651
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/772651 | IMPROVED METHOD FOR MANUFACTURING ALLULOSE | Oct 28, 2020 | Pending |
Array
(
[id] => 18065515
[patent_doc_number] => 20220396602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => MUTANT URACIL DNA GLYCOSYLASE WITH IMPROVED THERMAL SENSITIVITY
[patent_app_type] => utility
[patent_app_number] => 17/264509
[patent_app_country] => US
[patent_app_date] => 2020-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11763
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17264509
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/264509 | Mutant Uracil DNA glycosylase with improved thermal sensitivity | Oct 21, 2020 | Issued |
Array
(
[id] => 20386809
[patent_doc_number] => 12486528
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-02
[patent_title] => Compositions and methods for measuring and inhibiting calpain-5 activity
[patent_app_type] => utility
[patent_app_number] => 17/767280
[patent_app_country] => US
[patent_app_date] => 2020-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 32
[patent_no_of_words] => 15715
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17767280
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/767280 | Compositions and methods for measuring and inhibiting calpain-5 activity | Oct 8, 2020 | Issued |
Array
(
[id] => 17124424
[patent_doc_number] => 20210299192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => COMPOSITION FOR ANTI-OXIDATION, ORAL HEALTH, IMMUNITY REGULATION AND EXERCISE PROMOTION, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/065040
[patent_app_country] => US
[patent_app_date] => 2020-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9836
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17065040
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/065040 | COMPOSITION FOR ANTI-OXIDATION, ORAL HEALTH, IMMUNITY REGULATION AND EXERCISE PROMOTION, AND USES THEREOF | Oct 6, 2020 | Abandoned |
Array
(
[id] => 19018968
[patent_doc_number] => 20240075139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => Antibodies against infectious pathogens and method for production thereof
[patent_app_type] => utility
[patent_app_number] => 17/766705
[patent_app_country] => US
[patent_app_date] => 2020-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12613
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17766705
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/766705 | Antibodies against infectious pathogens and method for production thereof | Oct 6, 2020 | Pending |
Array
(
[id] => 18036226
[patent_doc_number] => 20220380441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => ANTIBODY COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B VIRUS INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/637605
[patent_app_country] => US
[patent_app_date] => 2020-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47770
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17637605
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/637605 | ANTIBODY COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B VIRUS INFECTION | Aug 27, 2020 | Abandoned |
Array
(
[id] => 16656043
[patent_doc_number] => 20210052679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => PROBIOTIC DELIVERY OF GUIDED ANTIMICROBIAL PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 16/997036
[patent_app_country] => US
[patent_app_date] => 2020-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12627
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16997036
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/997036 | PROBIOTIC DELIVERY OF GUIDED ANTIMICROBIAL PEPTIDES | Aug 18, 2020 | Abandoned |
Array
(
[id] => 19396199
[patent_doc_number] => 12070528
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-27
[patent_title] => Collagen and micronized placental tissue compositions and methods of making and using the same
[patent_app_type] => utility
[patent_app_number] => 16/989170
[patent_app_country] => US
[patent_app_date] => 2020-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 13066
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16989170
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/989170 | Collagen and micronized placental tissue compositions and methods of making and using the same | Aug 9, 2020 | Issued |
Array
(
[id] => 16899060
[patent_doc_number] => 20210177976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => STABILIZED FACTOR IX FORMULATIONS CONTAINING TREHALOSE
[patent_app_type] => utility
[patent_app_number] => 16/940885
[patent_app_country] => US
[patent_app_date] => 2020-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4782
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16940885
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/940885 | STABILIZED FACTOR IX FORMULATIONS CONTAINING TREHALOSE | Jul 27, 2020 | Abandoned |
Array
(
[id] => 16883804
[patent_doc_number] => 20210169999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => ENOLASE 1 (ENO1) COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/931643
[patent_app_country] => US
[patent_app_date] => 2020-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35185
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16931643
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/931643 | ENOLASE 1 (ENO1) COMPOSITIONS AND USES THEREOF | Jul 16, 2020 | Abandoned |